Overview

·China’s Biggest Insulin and Enzyme Preparations Production Base

·China’s Biggest Instant Food and Portable Water Production Base

·China’s Biggest Vaccine Industrialization Base

Covering Eight Growth Priorities of the Pharmaceutical Industry:

Biomedicine, Chemical Drugs, Traditional Chinese Medicine(TCM), NaturalMedicines, Medical Devices, In-vitro Diagnostics, CRO Services, Biotechnology

In 2022, TEDA saw an output value of 65.69 billion yuan from its healthcare industry.

After 30 years of development, five major industrial clusters have been formed in the fields of biomedicine, medical devices,pharmaceutical R&D outsourcing, food and drink, and big health.

Biomedicine

Medical Devices

CRO

Food & Bevearges